Products

What will AGI do for Benproperine phosphate?

This classification denotes an antitussive agent with the molecular formula C21H27NO.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S831Z48C5W, chemically known as piperidine, 1-(1-methyl-2-((alpha-phenyl-o-tolyl)oxy)ethyl)-, phosphate but more generally known as benproperine phosphate, which bears US NIH Compound Identifier 167811. European Medicines Agency schedules Benproperine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00705MIG. Most nations, for tariff and trade purposes, schedule benproperine phosphate under HS 29333999 and SITC 51574. As of Q4 2014, BENPROPERINE PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: CC(COC1CCCCC1CC2CCCCC2)N3CCCCC3.OP(=O)(O)O.

How AGI delivers it

Four ways AGI delivers for Benproperine phosphate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Benproperine phosphate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Benproperine phosphate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Benproperine phosphate connects

measured by

  • Assay Puritymodel
  • Counter-Ion Contentmodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Residual Solventmodel